Phamacology Flashcards
How urine pH affects drug clearance
- For an acidic drug, if urine is made basic then clearance will increase.
- For a basic drug, if urine is made acidic then clearance will increase.
Macrolide in Cystric Fibrosis
1) Anti-inflammatory
2) Reduce sputum viscoelasticity, airway adhesion of P. aeruginosa, and increase the killing of mucoid P. aeruginosa
3) Low dose azithromycin has been shown to improve macrophage function, reduce neutrophil counts in the bronchial lavage fluid and reduce pulmonary tissue
Omeprazole is assocaited with which electolyte disturnace
Hypomagnasaemia
The effect of Erythromycin on warfarin
- Bioavailability is unchanged but warfarin clearance is reduced.
- Erythromycin stimulates the liver enzymes to produce metabolites that bind to cytochrome P450, forming inactive complexes and, thereby, reducing the metabolism of warfarin which enhances its effect.
The oral bioavailability of warfarin is nearly 100%. Warfarin is highly bound (approximately 97%) to plasma protein, mainly albumin.
Bioavailability in cirrhosis
- Increased bioavailability.
- Bioavailability = 1 – Hepatic Extraction Ratio.
- Hepatic extraction ratio (HER) is determined by Total clearance of drug by liver over Total liver blood flow.
- In patients with cirrhosis, there is reduced hepatic clearance or reduced 1st pass effect therefore a lower HER which then leads to increased bioavailability.
Bioavailability
Bioavailability = 1 - HER Bioavailability = AUC oral / AUC iv. =
Allopurinol and azathioprine
Allopurinol interferes with the metabolism of azathioprine, increasing plasma levels of 6-mercaptopurine which may result in potentially fatal blood dyscrasias. Bone marrow suppression occurs with azathioprine-allopurinol interaction.
Volume Distribution
VD = total amount of blood in the body/plasma concentration
Bio-availability
= 1 - hepatic extraction ratio
- cirrhosis - reduced hepatic blood flow and increased bioavailability
hepatic extraction ratio
= total clearance by the liver/total liver blood flow
- cirrhosis - reduced hepatic blood flow and increased bioavailability
T 1/2
= Volume distribution/clearance